Cladribine-related immunosuppression may have fostered graft-versus-host disease after lung transplant for pulmonary Langerhans cell histiocytosis

Pediatr Blood Cancer. 2019 Jan;66(1):e27477. doi: 10.1002/pbc.27477. Epub 2018 Sep 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Child, Preschool
  • Cladribine / adverse effects*
  • Fatal Outcome
  • Female
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / pathology
  • Histiocytosis, Langerhans-Cell / drug therapy*
  • Histiocytosis, Langerhans-Cell / immunology
  • Histiocytosis, Langerhans-Cell / surgery*
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Immunosuppressive Agents / adverse effects
  • Lung Diseases / drug therapy*
  • Lung Diseases / immunology
  • Lung Diseases / surgery*
  • Lung Transplantation / adverse effects*

Substances

  • Immunosuppressive Agents
  • Cladribine